Early reperfusion therapy in acute myocardial infarction in clinical practice - Results of the MITRA-plus registry;Frühe reperfusionstherapie beim myokardinfarkt im klinischen alltag - Ergebnisse aus dem MITRA-plus-register

Deutsches Arzteblatt

Volumn 104, Issue 30, 2007, Pages

  Zeymer, Uwe ^a,b   Gitt, Anselm ^a   Zahn, Ralf ^a   Schneider, Steffen ^a   Senges, Jochen ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Fibrinolytic therapy; Mortality; Myocardial infarction; Prognosis; Reperfusion

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; BLOOD CLOT LYSIS; CLINICAL PRACTICE; DISEASE REGISTRY; HEART MUSCLE REPERFUSION; HUMAN; MAJOR CLINICAL STUDY; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; ST SEGMENT ELEVATION;

EID: 34547698731     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. The WHO 2006 Report - Working together for health. Genf 2006.
2. Fibrinolytic Therapy Trialists'(FTT) Collaborative Group: Indications for fibrinolytic therapy in suspected myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-22.
3. Baigent C, Collins R, Appleby P, Parish S, Sleight P, Peto R: ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. BMJ 1998; 316: 1337-43.
4. Zeymer U, Schröder R, Neuhaus KL: Patency, Perfusion und Prognose beim akuten Herzinfarkt. Herz 1999; 24: 421-9.
5. Keeley EC, Boura JA, Grines CL: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20.
6. Zeymer U, Schröder R, Machnig T, Neuhaus KL; Primary percutaneous coronary intervention accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardioal infarction. Am Heart J 2003; 146: 686-91.
7. Van de Werf F, Ardissino D, Betriu A et al.: Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003; 24: 28-66.
8. Hamm CW: Leitlinien zur Therapie des akuten koronaren Syndroms mit ST-Hebungen. Z Kardiol 2004; 93: 324-41.
9. Steg PG, Lopez-Sendon J, Lopez de Sa E et al.: External validity of clinical trials in acute myocardial infarction. Arch Intern Med 2007; 167: 68-73.
10. Brodie BR, Weintraub RA, Stuckey TD et al.: Outcomes of direct angioplasty for acute myocardial infarction in candidates and non-candidates for thrombolytic therapy. Am J Cardiol 1991; 67: 7-12.
11. Morrow DA, Antman EM, Charlesworth A et al.: TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an In TIME II trial substudy. Circulation 2000; 102: 2031-7.
12. Zeymer U, Senges J: Qualitätsregister in der Kardiologie. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2004; 47: 533-9.
13. Hasdai D, Topol EJ, Califf RM, Berger PB, Holmes DR: Cardiogenic shock complicating acute coronary syndromes. Lancet 2000; 356: 749-56.
14. Steg PG, Bonnefoy E, Chaubaud S et al.: Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty. Circulation 2003; 108: 2851-6.
15. Zeymer U, Arntz HR, Baubin M, Gulba D, Ellinger K, Nibbe L: Ver-besserung der Zusammenarbeit zwischen Notärzten und Kardiologen zur Optimierung der frühen Therapie bei akutem ST-Hebungsinfarkt. Notfall Rettungsmedizin 2004; 7: 475-8.